| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | DFNA5 |
| Uniprot No | O60443 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-496aa |
| 氨基酸序列 | MFAKATRNFLREVDADGDLIAVSNLNDSDKLQLLSLVTKKKRFWCWQRPKYQFLSLTLGDVLIEDQFPSPVVVESDFVKYEGKFANHVSGTLETALGKVKLNLGGSSRVESQSSFGTLRKQEVDLQQLIRDSAERTINLRNPVLQQVLEGRNEVLCVLTQKITTMQKCVISEHMQVEEKCGGIVGIQTKTVQVSATEDGNVTKDSNVVLEIPAATTIAYGVIELYVKLDGQFEFCLLRGKQGGFENKKRIDSVYLDPLVFREFAFIDMPDAAHGISSQDGPLSVLKQATLLLERNFHPFAELPEPQQTALSDIFQAVLFDDELLMVLEPVCDDLVSGLSPTVAVLGELKPRQQQDLVAFLQLVGCSLQGGCPGPEDAGSKQLFMTAYFLVSALAEMPDSAAALLGTCCKLQIIPTLCHLLRALSDDGVSDLEDPTLTPLKDTERFGIVQRLFASADISLERLKSSVKAVILKDSKVFPLLLCITLNGLCALGREHS |
| 分子量 | 81 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人DFNA5蛋白的3篇代表性文献，涵盖其功能、作用机制及疾病相关性：
---
1. **文献名称**：*DFNA5 (ICERE-1) contributes to prostate cancer cell growth through inflammatory signaling*
**作者**：Kim et al. (2017)
**摘要**：研究揭示重组DFNA5蛋白通过激活NF-κB等炎症信号通路促进前列腺癌细胞增殖，提示其在肿瘤微环境中的促癌作用可能与慢性炎症相关。
---
2. **文献名称**：*Gasdermin E (DFNA5) triggers pyroptosis by forming pores in the plasma membrane*
**作者**：Wang et al. (2017)
**摘要**：该研究发现重组人DFNA5蛋白(即Gasdermin E)被caspase-3切割后，其N端结构域可在细胞膜上形成孔洞，诱导细胞焦亡(pyroptosis)，从而在癌症治疗反应中发挥关键作用。
---
3. **文献名称**：*Structural basis of DFNA5 oligomerization and pore formation*
**作者**：Zhang et al. (2020)
**摘要**：通过冷冻电镜技术解析重组DFNA5蛋白的寡聚化结构，阐明其形成跨膜孔的分子机制，为靶向DFNA5的疾病治疗提供结构生物学依据。
---
**可选补充**
4. **文献名称**：*DFNA5 mutations lead to hearing loss through increased apoptosis in cochlear cells*
**作者**：Bischoff et al. (2004)
**摘要**：早期研究证明DFNA5基因突变导致其重组蛋白异常激活，引发耳蜗细胞过度凋亡，进而引起常染色体显性遗传性听力损失。
---
**说明**：上述文献涵盖DFNA5的促癌机制(Kim)、焦亡机制(Wang)、结构解析(Zhang)及听力损失病理(Bischoff)，均为领域内关键研究。如需具体文章链接或补充信息，可进一步提供关键词辅助检索。
DFNA5. also known as gasdermin E (GSDME), is a protein encoded by the DFNA5 gene, initially linked to autosomal dominant nonsyndromic hearing loss. It belongs to the gasdermin family, which mediates pyroptosis—a form of inflammatory programmed cell death. Full-length DFNA5 is autoinhibited, with its N-terminal pore-forming domain blocked by the C-terminal domain. Upon cleavage by caspase-3 or granzyme B during apoptosis or immune responses, the active N-terminal fragment oligomerizes to form transmembrane pores, disrupting membrane integrity and triggering cell lysis.
Recombinant human DFNA5 protein, produced in vitro using expression systems like E. coli or mammalian cells, is pivotal for studying its structure-function relationship and regulatory mechanisms. Researchers often engineer variants lacking the auto-cleavage domain to enhance stability. Dysregulated DFNA5 expression is implicated in cancer, as its epigenetic silencing in tumors may suppress pyroptosis and promote chemoresistance. Conversely, restoring DFNA5 activity could induce cancer cell death, highlighting therapeutic potential. In hearing loss, DFNA5 mutations cause exon-skipping, leading to toxic protein aggregates in inner ear cells, though precise pathogenic mechanisms remain under investigation. Recombinant DFNA5 tools aid in dissecting these pathways and developing targeted interventions.
×
